Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
12:37pm, Thursday, 30'th May 2024
Lilly (LLY) reported earnings 30 days ago. What's next for the stock?
Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit
07:30am, Thursday, 30'th May 2024
If you're wondering which overvalued blue-chip stocks to ditch right now, look no further. The best investors pay attention to a stock's valuation.
Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?
06:15am, Wednesday, 29'th May 2024
Eli Lilly sells two of the most sought-after treatments -- those prescribed for weight management. Mounjaro and Zepbound are driving double-digit earnings growth at the big pharma company.
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
06:00am, Wednesday, 29'th May 2024
New $6.5 million commitment will help strengthen systems to improve health outcomes across resource-limited areas in India GENEVA , May 29, 2024 /PRNewswire/ -- During the World Health Assembly toda
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Tuesday, 28'th May 2024
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
10:00am, Tuesday, 28'th May 2024
INDIANAPOLIS , May 28, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024. Patrik Jonsson, execut
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
04:39am, Tuesday, 28'th May 2024
Eli Lilly stock could reach $1,001 per share, according to a Wall Street analyst from BMO Capital. Tirzepatide sales are off the charts but could be much higher if not for supply constraints.
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
09:06am, Monday, 27'th May 2024
Since 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites as well as updating existing manufacturing facilities.
Eli Lilly: Addressing Supply Challenges Should Accelerate Growth
03:19pm, Sunday, 26'th May 2024
Eli Lilly's shares reached new all-time highs after the company increased full-year revenue and EPS guidance. The company's growth is currently supply-constrained and the growth of tirzepatide in the
Got $500? 3 Pharma Stocks to Buy and Hold Forever
10:15am, Sunday, 26'th May 2024
Vertex Pharmaceuticals is in the midst of a major diversification plan. Eli Lilly's medicines for diabetes and obesity are incredibly hot sellers.
How digital health companies are capitalizing on the GLP-1 boom
09:00am, Saturday, 25'th May 2024
Some analysts estimate that anti-obesity medications could grow into a $100 billion industry by the end of the decade. Companies including Calibrate, Ro and WeightWatchers are looking to capitalize on
3 High-Flying Stocks That Could Soar Even More
06:47am, Saturday, 25'th May 2024
Eli Lilly is just getting started with its powerful obesity drug and a loaded pipeline. It's not too late to invest in scorching-hot Novo Nordisk.
Eli Lilly CEO David Ricks on $.5.3 billion weight loss drug investment
08:49pm, Friday, 24'th May 2024
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m.
Lilly to Invest $5.3 Billion for Weight-Loss Drug Supply
10:40am, Friday, 24'th May 2024
Eli Lilly & Co.��will spend $5.3 billion to boost production of a key ingredient in its weight-loss and diabetes shots after the treatments' explosive popularity led to shortages. Simone Foxman re
Eli Lilly to spend $5.3 billion to boost Zepbound, Mounjaro manufacturing
10:33am, Friday, 24'th May 2024
Eli Lilly & Co. said Friday that it has more than doubled its investment in a Lebanon, Ind., site to boost manufacturing capacity for its popular weight-loss drug Zepbound and diabetes treatment Mounj
